Aethlon Medical Inc (AEMD)

[stockhorizon]

Now THAT's useful technology. Aethlon should initiate another costly study to validate how 15 years of useless, made-for-press-release studies have resulted in the loss of any chance to ever sell a hemopurifier because...drumroll...technology moves forward and there are better, less costly and available solutions to virtually ALL of the fields of play that Aethlon pretends to play in.